Mezavant

Array
(
    [ID] => 10885
    [post_author] => 16
    [post_date] => 2014-12-15 19:04:46
    [post_date_gmt] => 2014-12-15 22:04:46
    [post_content] => 
Forma farmacéutica
Comprimidos Recubiertos de Liberación Prolongada
Composición
Cada Comprimido Recubierto de Liberación Prolongada contiene:
Mesalazina 1,2 g.
Acción terapéutica
Agentes antiinflamatorios intestinales del grupo ácido aminosalicílico y similares
Indicaciones
Indicación para adultos, incluidas personas de edad avanzada (>65 años): Mezavant está indicado para la inducción y mantenimiento de la remisión clínica y endoscópica en pacientes con colitis ulcerosa activa de leve a moderada.

Indicación pediátrica (que pesen más de 50 kg y tengan 10 años o más): Mezavant está indicado para la inducción y mantenimiento de la remisión clínica y endoscópica en pacientes con colitis ulcerosa activa de leve a moderada.
Presentaciones
Envases conteniendo 30 y 60 Comprimidos Recubiertos de Liberación Prolongada.

 
    [post_title] => Mezavant
    [post_excerpt] => Agente antiinflamatorio intestinal del grupo ácido aminosalicílico y similares
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => mezavant-2
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2024-03-07 09:57:41
    [post_modified_gmt] => 2024-03-07 12:57:41
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://www.bago.com.ar/vademecum/?post_type=productos&p=10885
    [menu_order] => 0
    [post_type] => productos
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
    [prospecto_para_pacientes] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19254
                    [post_author] => 16
                    [post_date] => 2024-03-07 08:41:32
                    [post_date_gmt] => 2024-03-07 11:41:32
                    [post_content] => 
                    [post_title] => Información para el paciente MEZAVANT Dispo 11543-23
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => informacion-para-el-paciente-mezavant-dispo-11543-23
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-03-07 08:41:32
                    [post_modified_gmt] => 2024-03-07 11:41:32
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => http://www.bago.com.ar/vademecum/wp-content/uploads/2024/03/Informacion-para-el-paciente-MEZAVANT-Dispo-11543-23.pdf
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [url_para_mayor_informacion_video] => 
    [url_para_mayor_informacion] => 
    [url_productos_consumo_masivo] => 
    [prospecto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19253
                    [post_author] => 16
                    [post_date] => 2024-03-07 08:40:34
                    [post_date_gmt] => 2024-03-07 11:40:34
                    [post_content] => 
                    [post_title] => Prospecto MEZAVANT Dispo 11543-23
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => prospecto-mezavant-dispo-11543-23
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-03-07 08:40:34
                    [post_modified_gmt] => 2024-03-07 11:40:34
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => http://www.bago.com.ar/vademecum/wp-content/uploads/2024/03/Prospecto-MEZAVANT-Dispo-11543-23.pdf
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [presentacion_img] => Array
        (
        )

    [logo_img] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 11126
                    [post_author] => 16
                    [post_date] => 2015-02-12 16:59:20
                    [post_date_gmt] => 2015-02-12 16:59:20
                    [post_content] => 
                    [post_title] => logo_lanzamiento_mezavant.jpg
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => open
                    [post_password] => 
                    [post_name] => logo_lanzamiento_mezavant-jpg-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2015-02-12 16:59:20
                    [post_modified_gmt] => 2015-02-12 16:59:20
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://www.bago.com.ar/vademecum/?attachment_id=11126
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => image/jpeg
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [foto_producto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19250
                    [post_author] => 16
                    [post_date] => 2024-03-07 08:17:47
                    [post_date_gmt] => 2024-03-07 11:17:47
                    [post_content] => 
                    [post_title] => banner-mezavant (1)
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => banner-mezavant-1
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-03-07 08:17:47
                    [post_modified_gmt] => 2024-03-07 11:17:47
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => http://www.bago.com.ar/vademecum/wp-content/uploads/2024/03/banner-mezavant-1.png
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => image/png
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [fotos_lanzamiento] => Array
        (
        )

    [especialidad] => Array
        (
        )

    [marca] => Array
        (
            [0] => Mezavant
        )

    [principio_activo] => Array
        (
            [0] => Mesalazina
        )

    [post_content_formatted] => 
Forma farmacéutica
Comprimidos Recubiertos de Liberación Prolongada
Composición
Cada Comprimido Recubierto de Liberación Prolongada contiene:

Mesalazina 1,2 g.
Acción terapéutica
Agentes antiinflamatorios intestinales del grupo ácido aminosalicílico y similares
Indicaciones
Indicación para adultos, incluidas personas de edad avanzada (>65 años): Mezavant está indicado para la inducción y mantenimiento de la remisión clínica y endoscópica en pacientes con colitis ulcerosa activa de leve a moderada.
Indicación pediátrica (que pesen más de 50 kg y tengan 10 años o más): Mezavant está indicado para la inducción y mantenimiento de la remisión clínica y endoscópica en pacientes con colitis ulcerosa activa de leve a moderada.
Presentaciones
Envases conteniendo 30 y 60 Comprimidos Recubiertos de Liberación Prolongada.
 

)

Array
(
    [_wp_attached_file] => Array
        (
            [0] => prospectos/Prospecto-MEZAVANT-Dispo-11543-23.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:8:"filesize";i:138528;}
        )

)

Array
(
    [_wp_attached_file] => Array
        (
            [0] => 2024/03/Informacion-para-el-paciente-MEZAVANT-Dispo-11543-23.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:8:"filesize";i:65133;}
        )

)

anexo_congre_single